Illustration of a lung cancer patient receiving radiation therapy, highlighting the precision of intensity-modulated radiation therapy (IMRT).
Radiation Therapy Advances in Lung Cancer Treatment

Findings from a recent study conducted by scientists at The University of Texas MD Anderson.

Microscopic view of the coronavirus, highlighting the link between COVID-19.
Neuropsychiatric Risks in COVID-19 Survivors: Key Study Findings

Researchers employed a large, binational cohort (total n = 4,731,778) in a recent study that.

Semaglutide Helps Women Lose More Weight than Men, Study Finds
Semaglutide Helps Women Lose More Weight than Men, Study Finds

Researchers conducted a secondary analysis of the semaglutide treatment effect in individuals with obesity and.

GI cancer risk linked with UPF
GI Cancer Risk Linked to Ultra-Processed Food Consumption

Researchers examined the relationship between the intake of ultra-processed foods (UPF) and gastrointestinal (GI) cancers.

Endometrial Cancer
Endometrial Cancer: AI Identifies High-Risk Subtypes

Endometrial cancer is the most common gynecologic cancer, and a discovery made by researchers at.

gut bacteria
Gut Microbiome Boost Mental Resilience & Reduce Anxiety

In a recent study published in Nature Mental Health, researchers identified brain-gut microbiome (BGM) patterns.

New Research Challenges Premature Baby Care Practices
New Research Challenges Premature Baby Care Practices

According to recent research done by University of Sydney experts, giving very preterm babies high.

Person using a glucose meter to check blood sugar levels, illustrating Type 2 diabetes monitoring.
MicroRNAs Predict Type 2 Diabetes Progression in Youth

In the last 20 years, the number of young individuals with type 2 diabetes who.

Researchers at Baylor College of Medicine identify new therapeutic targets for cancer, expanding treatment options.
Therapeutic Targets Expand Cancer Treatment Options

The range of options for treating cancer has increased as a result of research at.

Elderly woman with dementia checking her glucose level, highlighting the importance of GLP-1 agonists in reducing dementia risk for type 2 diabetes patients.
Dementia Risk Reduced by GLP-1 Agonists

In summary, patients with type 2 diabetes who use GLP-1 agonists, such as Ozempic, have.